Clinical Case of Successful Therapy for the Patient with Autism by use of Fetal Stem Cells
Article Sidebar
Main Article Content
Abstract
More than 60 million persons all over the world are living with the diagnosis of “Autism”, in accordance with the UNO. According to the WHO, almost every hundredth child is a sufferer of ASD. Such figures emphasize globalization of the problem, and its impact not only on the child’s family but also on the economies of entire countries.
Autism diagnosis is difficult and based on the general symptoms in kids. Today, the neuroimaging techniques (methods of functional Magnetic Resonance Imaging (MRI) and MRI tractography), Electroencephalography (EEG), evoked cognitive potentials and dynamic monitoring of the results help with an objective evaluation of stem cell therapy.
Treatment options in modern pharmacology and rehabilitation psychotherapy for ASD kids are limited. Therapy methods do not ensure a full integration into social life and personality awareness. To alleviate likely problems in society, different therapeutic approaches exist that might reduce the manifestation of the various autism symptoms. FSC therapy is one such innovative method that has recently become enough popular.
We inform about the clinical case of successful treatment using fetal stem cells for a child with autism followed by the period of 1-year follow-up showing significant clinical results. Over one year, the positive changes that had been proved by the ATEC questionnaire, the EEG results, and MRI-tractography were noted by the patient’s family. As emphasized in the clinical case report, fetal stem cell therapy is a promising and efficient treatment for children with autism. All that was sufficiently confirmed by the results acquired because we saw an overall improvement in this patient.
Article Details
Copyright (c) 2024 Sinelnyk AA, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal of Stem Cell Therapy and Transplantation is committed in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. In order to use the Open Access paradigm to the maximum extent in true terms as free of charge online access along with usage right, we grant usage rights through the use of specific Creative Commons license.
License: Copyright © 2017 - 2025 | 
Open Access by Journal of Stem Cell Therapy and Transplantation is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at Heighten Science Publications Inc.
With this license, the authors are allowed that after publishing with the journal, they can share their research by posting a free draft copy of their article to any repository or website.
Compliance 'CC BY' license helps in:
| Permission to read and download | ✓ |
| Permission to display in a repository | ✓ |
| Permission to translate | ✓ |
| Commercial uses of manuscript | ✓ |
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
Bradstreet JJ, Sych N, Antonucci N, Ivankova O, Matyashchuk I, Demchuk M, et al. Efficacy of fetal stem cell transplantation in autism spectrum disorders: an open-labeled pilot study. Cell Transplant. 2014;23(1 Suppl):105-112. Available from: https://doi.org/10.3727/096368914x684916
Salari N, Rasoulpoor S, Rasoulpoor S, Shohaimi S, Jafarpour S, Abdoli N, et al. The global prevalence of autism spectrum disorder: a comprehensive systematic review and meta-analysis. Ital J Pediatr. 2022;48(1):112. Available from: https://doi.org/10.1186/s13052-022-01310-w
Qu J, Liu Z, Li L, Zou Z, He Z, Zhou L, et al. Efficacy and safety of stem cell therapy in children with autism spectrum disorders: a systematic review and meta-analysis. Front Pediatr. 2022;10:897398. Available from: https://doi.org/10.3389/fped.2022.897398
Rosner M, Schipany K, Hengstschläger M. The decision on the “optimal” human pluripotent stem cell. Stem Cells Transl Med. 2014;3:553-559. Available from: https://stemcellres.biomedcentral.com/articles/10.1186/s13287-023-03379-4
Ishii T, Eto K. Fetal stem cell transplantation: past, present, and future. World J Stem Cells. 2014;6(4):404-420. Available from: https://doi.org/10.4252%2Fwjsc.v6.i4.404
Larijani B, Aghayan HR, Goodarzi P, Arjmand B. GMP-grade human fetal liver-derived mesenchymal stem cells for clinical transplantation. Methods Mol Biol. 2014;1216:123-133. Available from: https://doi.org/10.1007/7651_2014_101
Rosner M, Horer S, Feichtinger M, Hengstschläger M. Multipotent fetal stem cells in reproductive biology research. Stem Cell Res Ther. 2023;14:157. Available from: https://doi.org/10.1186/s13287-023-03379-4
Brands K, Colvin E, Williams LJ, Wang R, Lock RB, Tuch BE. Reduced immunogenicity of first-trimester human fetal pancreas. Diabetes. 2008 Mar;57(3):572-580. Available from: https://doi.org/10.2337/db07-0720a
Palmer C, Coronel R, Liste I. Treatment of Parkinson’s disease using human stem cells. J Stem Cell Res Med. 2016;1(3):71-77. Available from: http://dx.doi.org/10.15761/JSCRM.1000113
Genchi A, Brambilla E, Sangalli F, Radaelli M, Bacigaluppi M, Furlan R, et al. Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study. Nat Med. 2023;29:75-85. Available from: https://doi.org/10.1038/s41591-022-02097-3
Levi AD, Anderson KD, Okonkwo DO, Park P, Bryce TN, Kurpad SN, et al. Clinical outcomes from a multi-center study of human neural stem cell transplantation in chronic cervical spinal cord injury. J Neurotrauma. 2019;36(6):891-902. Available from: https://doi.org/10.1089/neu.2018.5843
Ottoboni L, von Wunster B, Martino G. Therapeutic plasticity of neural stem cells. Front Neurol. 2020;11:48. Available from: https://doi.org/10.3389/fneur.2020.00148
De Gioia R, Biella F, Citterio G, Rizzo F, Abati E, Nizzardo M, et al. Neural stem cell transplantation for neurodegenerative diseases. Int J Mol Sci. 2020;21(9):3103. Available from: https://doi.org/10.3390/ijms21093103
Zhang G, Zhu Z, Wang H, Yu Y, Chen W, Waqas A, et al. Exosomes derived from human neural stem cells stimulated by interferon gamma improve therapeutic ability in ischemic stroke model. J Adv Res. 2020;24:435-445. Available from: https://doi.org/10.1016/j.jare.2020.05.017
Kahroba H, Ramezani B, Maadi H, Sadeghi MR, Jaberie H, Ramezani F. The role of Nrf2 in neural stem/progenitor cells: from maintaining stemness and self-renewal to promoting differentiation capability and facilitating therapeutic application in neurodegenerative disease. Ageing Res Rev. 2021;65:101211. Available from: https://doi.org/10.1016/j.arr.2020.101211
Ahmadian-Moghadam H, Sadat-Shirazi M, Zarrindast MR. Therapeutic potential of stem cells for treatment of neurodegenerative diseases. Biotechnol Lett. 2020;42:1073-1101. Available from: https://doi.org/10.1007/s10529-020-02886-1
Nair S, Rocha-Ferreira E, Fleiss B, Nijboer CH, Gressens P, Mallard C, et al. Neuroprotection offered by mesenchymal stem cells in perinatal brain injury: role of mitochondria, inflammation, and reactive oxygen species. J Neurochem. 2021;158(1):59-73. Available from: https://doi.org/10.1111/jnc.15267
Amici SA, Dong J, Guerau-de-Arellano M. Molecular mechanisms modulating the phenotype of macrophages and microglia. Front Immunol. 2017;8:1520. Available from: https://doi.org/10.3389/fimmu.2017.01520
Okano H. Neural stem cells and strategies for the regeneration of the central nervous system. Proc Jpn Acad Ser B Phys Biol Sci. 2010;86(4):438-450. Available from: https://doi.org/10.2183%2Fpjab.86.438
Al Backer NB. Correlation between Autism Treatment Evaluation Checklist (ATEC) and Childhood Autism Rating Scale (CARS) in the evaluation of autism spectrum disorder. Sudan J Paediatr. 2016;16(1):17-22. Available from: https://pubmed.ncbi.nlm.nih.gov/27651549/
Aoki Y, Abe O, Nippashi Y, Yamasue H. Comparison of white matter integrity between autism spectrum disorder subjects and typically developing individuals: a meta-analysis of diffusion tensor imaging tractography studies. Mol Autism. 2013;4(1):25. Available from: https://doi.org/10.1186/2040-2392-4-25
Zong F, You Z, Zhou L, Deng X. Language function of the superior longitudinal fasciculus in patients with arteriovenous malformation as evidenced by automatic fiber quantification. Front Radiol. 2023;3:1121879. Available from: https://doi.org/10.3389%2Ffradi.2023.1121879
Ikuta T, Shafritz KM, Bregman J, Peters BD, Gruner P, Malhotra AK, et al. Abnormal cingulum bundle development in autism: a probabilistic tractography study. Psychiatry Res Neuroimaging. 2014;221(1):63-68. Available from: https://doi.org/10.1016%2Fj.pscychresns.2013.08.002
Connaughton M, O'Hanlon E, McGrath J. Chapter 7 - White matter microstructure in autism. In: Kana RK, editor. The Neuroscience of Autism. Academic Press; 2022; 127-156.